Literature DB >> 21672919

Temporal requirement for high SMN expression in SMA mice.

Thanh T Le1, Vicki L McGovern, Isaac E Alwine, Xueyong Wang, Aurelie Massoni-Laporte, Mark M Rich, Arthur H M Burghes.   

Abstract

Spinal muscular atrophy (SMA) is caused by loss of the survival motor neuron 1 gene (SMN1) and retention of the SMN2 gene, resulting in reduced SMN. SMA mice can be rescued with high expression of SMN in neurons, but when is this high expression required? We have developed a SMA mouse with inducible expression of SMN to address the temporal requirement for high SMN expression. Both embryonic and early postnatal induction of SMN resulted in a dramatic increase in survival with some mice living greater than 200 days. The mice had no marked motor deficits and neuromuscular junction (NMJ) function was near normal thus it appears that induction of SMN in postnatal SMA mice rescues motor function. Early postnatal SMN induction, followed by a 1-month removal of induction at 28 days of age, resulted in no morphological or electrophysiological abnormalities at the NMJ and no overt motor phenotype. Upon removal of SMN induction, five mice survived for just over 1 month and two female mice have survived past 8 months of age. We suggest that there is a postnatal period of time when high SMN levels are required. Furthermore, two copies of SMN2 provide the minimal amount of SMN necessary to maintain survival during adulthood. Finally, in the course of SMA, early induction of SMN is most efficacious.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21672919      PMCID: PMC3159555          DOI: 10.1093/hmg/ddr275

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  86 in total

1.  Correlation between severity and SMN protein level in spinal muscular atrophy.

Authors:  S Lefebvre; P Burlet; Q Liu; S Bertrandy; O Clermont; A Munnich; G Dreyfuss; J Melki
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

Review 2.  The neurobiology of childhood spinal muscular atrophy.

Authors:  T O Crawford; C A Pardo
Journal:  Neurobiol Dis       Date:  1996-04       Impact factor: 5.996

3.  An 11 base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: further evidence for SMN as the primary SMA-determining gene.

Authors:  D W Parsons; P E McAndrew; U R Monani; J R Mendell; A H Burghes; T W Prior
Journal:  Hum Mol Genet       Date:  1996-11       Impact factor: 6.150

4.  Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.

Authors:  P E McAndrew; D W Parsons; L R Simard; C Rochette; P N Ray; J R Mendell; T W Prior; A H Burghes
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

5.  The genetic component in child mortality.

Authors:  D F Roberts; J Chavez; S D Court
Journal:  Arch Dis Child       Date:  1970-02       Impact factor: 3.791

6.  Deletion of murine Smn exon 7 directed to liver leads to severe defect of liver development associated with iron overload.

Authors:  Jérémie M Vitte; Bénédicte Davoult; Natacha Roblot; Michèle Mayer; Vandana Joshi; Sabrina Courageot; François Tronche; Jacqueline Vadrot; Marie Helene Moreau; François Kemeny; Judith Melki
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

7.  A novel nuclear structure containing the survival of motor neurons protein.

Authors:  Q Liu; G Dreyfuss
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

8.  Control of memory formation through regulated expression of a CaMKII transgene.

Authors:  M Mayford; M E Bach; Y Y Huang; L Wang; R D Hawkins; E R Kandel
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

9.  Identification and characterization of a spinal muscular atrophy-determining gene.

Authors:  S Lefebvre; L Bürglen; S Reboullet; O Clermont; P Burlet; L Viollet; B Benichou; C Cruaud; P Millasseau; M Zeviani
Journal:  Cell       Date:  1995-01-13       Impact factor: 41.582

10.  Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients.

Authors:  M Gennarelli; M Lucarelli; F Capon; A Pizzuti; L Merlini; C Angelini; G Novelli; B Dallapiccola
Journal:  Biochem Biophys Res Commun       Date:  1995-08-04       Impact factor: 3.575

View more
  71 in total

1.  Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction.

Authors:  Rocky G Gogliotti; Katharina A Quinlan; Courtenay B Barlow; Christopher R Heier; C J Heckman; Christine J Didonato
Journal:  J Neurosci       Date:  2012-03-14       Impact factor: 6.167

2.  Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.

Authors:  Tara L Martinez; Lingling Kong; Xueyong Wang; Melissa A Osborne; Melissa E Crowder; James P Van Meerbeke; Xixi Xu; Crystal Davis; Joe Wooley; David J Goldhamer; Cathleen M Lutz; Mark M Rich; Charlotte J Sumner
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

3.  Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMNΔ7 mouse model of SMA.

Authors:  Chitra C Iyer; Vicki L McGovern; Jason D Murray; Sara E Gombash; Phillip G Zaworski; Kevin D Foust; Paul M L Janssen; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2015-08-13       Impact factor: 6.150

Review 4.  Disease mechanisms and therapeutic approaches in spinal muscular atrophy.

Authors:  Sarah Tisdale; Livio Pellizzoni
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

Review 5.  Spliceosomal small nuclear ribonucleoprotein biogenesis defects and motor neuron selectivity in spinal muscular atrophy.

Authors:  Eileen Workman; Stephen J Kolb; Daniel J Battle
Journal:  Brain Res       Date:  2012-02-28       Impact factor: 3.252

6.  SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice.

Authors:  James Palacino; Susanne E Swalley; Cheng Song; Atwood K Cheung; Lei Shu; Xiaolu Zhang; Mailin Van Hoosear; Youngah Shin; Donovan N Chin; Caroline Gubser Keller; Martin Beibel; Nicole A Renaud; Thomas M Smith; Michael Salcius; Xiaoying Shi; Marc Hild; Rebecca Servais; Monish Jain; Lin Deng; Caroline Bullock; Michael McLellan; Sven Schuierer; Leo Murphy; Marcel J J Blommers; Cecile Blaustein; Frada Berenshteyn; Arnaud Lacoste; Jason R Thomas; Guglielmo Roma; Gregory A Michaud; Brian S Tseng; Jeffery A Porter; Vic E Myer; John A Tallarico; Lawrence G Hamann; Daniel Curtis; Mark C Fishman; William F Dietrich; Natalie A Dales; Rajeev Sivasankaran
Journal:  Nat Chem Biol       Date:  2015-06-01       Impact factor: 15.040

7.  Temporal requirement for SMN in motoneuron development.

Authors:  Le T Hao; Phan Q Duy; James D Jontes; Marc Wolman; Michael Granato; Christine E Beattie
Journal:  Hum Mol Genet       Date:  2013-03-03       Impact factor: 6.150

8.  SMN-targeted therapeutics for spinal muscular atrophy: are we SMArt enough yet?

Authors:  Kathryn J Swoboda
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

9.  Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation.

Authors:  Shingo Kariya; Teresa Obis; Caterina Garone; Turgay Akay; Fusako Sera; Shinichi Iwata; Shunichi Homma; Umrao R Monani
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

10.  Deletion of atrophy enhancing genes fails to ameliorate the phenotype in a mouse model of spinal muscular atrophy.

Authors:  Chitra C Iyer; Vicki L McGovern; Dawnne O Wise; David J Glass; Arthur H M Burghes
Journal:  Neuromuscul Disord       Date:  2014-02-25       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.